Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

OBJECTIVE: To date, no randomised trials have compared the efficacy of vonoprazan and amoxicillin dual therapy with other standard regimens for Helicobacter pylori treatment. This study aimed to investigate the efficacy of the 7-day vonoprazan and low-dose amoxicillin dual therapy as a first-line H....

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Sho, Gotoda, Takuji, Kusano, Chika, Ikehara, Hisatomo, Ichijima, Ryoji, Ohyauchi, Motoki, Ito, Hirotaka, Kawamura, Masashi, Ogata, Yohei, Ohtaka, Masahiko, Nakahara, Moriyasu, Kawabe, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Helicobacter Pylori
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282559/
https://www.ncbi.nlm.nih.gov/pubmed/31915235
http://dx.doi.org/10.1136/gutjnl-2019-319954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282559/
https://www.ncbi.nlm.nih.gov/pubmed/31915235
http://dx.doi.org/10.1136/gutjnl-2019-319954

Ejemplares similares